|
1
|
López-Sánchez I, Sanz-Garcia M and Lazo
PA: Plk3 interacts with and specifically phosphorylates VRK1 in
Ser342, a downstream target in a pathway that induces Golgi
fragmentation. Mol Cell Biol. 29:1189–1201. 2009. View Article : Google Scholar :
|
|
2
|
Niranjan G, Mohanavalli V, Srinivasan AR
and Ramesh R: Serum lipid peroxides and magnesium levels following
three months of treatment with pioglitazone in patients with type-2
diabetes mellitus. Diabetes Metab Syndr. 7:35–37. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ogden CL, Carroll MD, Curtin LR, Lamb MM
and Flegal KM: Prevalence of high body mass index in US children
and adolescents, 2007–2008. JAMA. 303:242–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Holl MG, Jaser SS, Womack JA, Jefferson VL
and Grey M: Metabolic risk and health behaviors in minority youth
at risk for type 2 diabetes. Diabetes Care. 34:193–197. 2011.
View Article : Google Scholar
|
|
5
|
Sambataro M, Perseghin G, Lattuada G,
Beltramello G, Luzi L and Pacini G: Lipid accumulation in
overweight type 2 diabetic subjects: Relationships with insulin
sensitivity and adipokines. Acta Diabetol. 50:301–307. 2013.
View Article : Google Scholar
|
|
6
|
Bozzetto L, De Natale C, Di Capua L, Della
Corte G, Patti L, Maione S, Riccardi G, Rivellese AA and Annuzzi G:
The association of hs-CRP with fasting and postprandial plasma
lipids in patients with type 2 diabetes is disrupted by dietary
monounsaturated fatty acids. Acta Diabetol. 50:273–276. 2013.
View Article : Google Scholar
|
|
7
|
Oda E: High-sensitivity C-reactive protein
and white blood cell count equally predict development of the
metabolic syndrome in a Japanese health screening population. Acta
Diabetol. 50:633–638. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tilich M and Arora RR: Modulation of
toll-like receptors by insulin. Am J Ther. 18:e130–e137. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lee JY, Ye J, Gao Z, Youn HS, Lee WH, Zhao
L, Sizemore N and Hwang DH: Reciprocal modulation of Toll-like
receptor-4 signaling pathways involving MyD88 and
phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated
fatty acids. J Biol Chem. 278:37041–37051. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee JY, Plakidas A, Lee WH, Heikkinen A,
Chanmugam P, Bray G and Hwang DH: Differential modulation of
toll-like receptors by fatty acids: Preferential inhibition by n-3
polyunsaturated fatty acids. J Lipid Res. 44:479–486. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee JY, Zhao L, Youn HS, Weatherill AR,
Tapping R, Feng L, Lee WH, Fitzgerald KA and Hwang DH: Saturated
fatty acid activates but polyunsaturated fatty acid inhibits
toll-like receptor 2 dimerized with toll-like receptor 6 or 1. J
Biol Chem. 279:16971–16979. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Devaraj S, Dasu MR, Rockwood J, Winter W,
Griffen SC and Jialal I: Increased toll-like receptor (TLR) 2 and
TLR4 expression in monocytes from patients with type 1 diabetes:
Further evidence of a proinflammatory state. J Clin Endocrinol
Metab. 93:578–583. 2008. View Article : Google Scholar
|
|
13
|
Bian H, Yan H, Zeng M, Rao S, Yao X, Zhou
J, Jia W and Gao X: Increased liver fat content and unfavorable
glucose profiles in subjects without diabetes. Diabetes Technol
Ther. 13:149–155. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Devaraj S, Glaser N, Griffen S,
Wang-Polagruto J, Miguelino E and Jialal I: Increased monocytic
activity and biomarkers of inflammation in patients with type 1
diabetes. Diabetes. 55:774–779. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Devaraj S, Cheung AT, Jialal I, Griffen
SC, Nguyen D, Glaser N and Aoki T: Evidence of increased
inflammation and microcirculatory abnormalities in patients with
type 1 diabetes and their role in microvascular complications.
Diabetes. 56:2790–2796. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dasu MR, Devaraj S, Park S and Jialal I:
Increased toll-like receptor (TLR) activation and TLR ligands in
recently diagnosed type 2 diabetic subjects. Diabetes Care.
33:861–868. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gan KX, Wang C, Chen JH, Zhu CJ and Song
GY: Mitofusin-2 ameliorates high-fat diet-induced insulin
resistance in liver of rats. World J Gastroenterol. 19:1572–1581.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Roth CL, Elfers CT, Figlewicz DP, Melhorn
SJ, Morton GJ, Hoofnagle A, Yeh MM, Nelson JE and Kowdley KV:
Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty
liver disease and increases hepatic resistin and toll-like receptor
activation. Hepatology. 55:1103–1111. 2012. View Article : Google Scholar
|
|
19
|
Obesity: Preventing and managing the
global epidemic. Report of a WHO consultation. World Health Organ
Tech Rep Ser. 894:i–xii. 1–253. 2000.
|
|
20
|
Choukem SP and Gautier JF: How to measure
hepatic insulin resistance? Diabetes Metab. 34(6 Pt 2): 664–673.
2008. View Article : Google Scholar
|
|
21
|
Uematsu S and Akira S: Toll-like receptors
and innate immunity. J Mol Med (Berl). 84:712–725. 2006. View Article : Google Scholar
|
|
22
|
Kawai T and Akira S: Signaling to
NF-kappaB by toll-like receptors. Trends Mol Med. 13:460–469. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wong SW, Kwon MJ, Choi AM, Kim HP,
Nakahira K and Hwang DH: Fatty acids modulate toll-like receptor 4
activation through regulation of receptor dimerization and
recruitment into lipid rafts in a reactive oxygen species-dependent
manner. J Biol Chem. 284:27384–27392. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Davis JE, Braucher DR, Walker-Daniels J
and Spurlock ME: Absence of Tlr2 protects against high-fat
diet-induced inflammation and results in greater insulin-stimulated
glucose transport in cultured adipocytes. J Nutr Biochem.
22:136–141. 2011. View Article : Google Scholar
|
|
25
|
Zang SS, Song A, Liu YX, Wang C, Song GY,
Li XL, Zhu YJ, Yu X, Li L, Liu CX, et al: Chinese medicine Jinlida
(JLD) ameliorates high-fat-diet induced insulin resistance in rats
by reducing lipid accumulation in skeletal muscle. Int J Clin Exp
Med. 8:4620–4634. 2015.PubMed/NCBI
|
|
26
|
Liu Y, Song A, Zang S, Wang C, Song G, Li
X, Zhu Y, Yu X, Li L, Wang Y and Duan L: Jinlida reduces insulin
resistance and ameliorates liver oxidative stress in high-fat fed
rats. J Ethnopharmacol. 162:244–252. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kurisu S, Iwasaki T, Ishibashi K, Mitsuba
N, Dohi Y, Nishioka K and Kihara Y: Effects of low-dose
pioglitazone on glucose control, lipid profiles,
renin-angiotensin-aldosterone system and natriuretic peptides in
diabetic patients with coronary artery disease. J Renin Angiotensin
Aldosterone Syst. 14:51–55. 2013. View Article : Google Scholar
|
|
28
|
Sturton G, Persson C and Barnes PJ: Small
airways: An important but neglected target in the treatment of
obstructive airway diseases. Trends Pharmacol Sci. 29:340–345.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kucuk T and Deveci S: Can
'chromohysteroscopy' help target endometrial biopsy in
postmenopausal bleeding? Eur J Gynaecol Oncol. 29:165–167.
2008.
|
|
30
|
Wang S and Fischer PM: Cyclin-dependent
kinase 9: A key transcriptional regulator and potential drug target
in oncology, virology and cardiology. Trends Pharmacol Sci.
29:302–313. 2008. View Article : Google Scholar : PubMed/NCBI
|
